.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Julphar
Colorcon
Argus Health
McKesson
Merck
Federal Trade Commission
Daiichi Sankyo
US Department of Justice
AstraZeneca

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,534,070 protect, and when does it expire?


Patent ► Subscribe protects FINACEA and is included in one NDA. There has been one Paragraph IV challenge on Finacea.

This patent has thirty patent family members in twenty-four countries.

Summary for Patent: ► Subscribe

Title: Composition with azelaic acid
Abstract:The invention relates to a pharmaceutical composition having the following constituents: azelaic acid, polyacrylic acid, triacylglyceride, propylene glycol, polysorbate, soya lecithin, water and salts. The composition is a hydrogel which is suited for the treatment of rosacea, presbyderma, melasma or skin irritations.
Inventor(s): Franke; Patrick (Berlin, DE), Gunther; Clemens (Berlin, DE), Riedl; Jutta (Inzlingen, DE)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:09/554,738
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bayer Hlthcare
FINACEA
azelaic acid
GEL;TOPICAL021470-001Dec 24, 2002RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany197 53 044Nov 19, 1997
Germany198 08 086Feb 20, 1998
PCT Information
PCT FiledNovember 18, 1998PCT Application Number:PCT/EP98/07370
PCT Publication Date:May 27, 1999PCT Publication Number: WO99/25332

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina013769► Subscribe
Austria210438► Subscribe
Australia1755199► Subscribe
Australia743437► Subscribe
Brazil9814214► Subscribe
Canada2311128► Subscribe
Czech Republic20001844► Subscribe
Czech Republic299116► Subscribe
Germany19881737► Subscribe
Germany59802473► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Johnson and Johnson
Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
Harvard Business School
Fish and Richardson
Novartis
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot